LTP2 Results Analysis-LaBaer (2024)
- Abbreviated Name
- LTP2 Results Analysis-LaBaer (2024)
- Lead Investigator
- LaBaer, Joshua — Arizona State University
- Coordinating Investigator
- Zheng, Yingye — Fred Hutchinson Cancer Center
- Involved Investigators
Abstract
We will assess the performance of the candidate antibody biomarkers using ELISA and the candidate serum protein markers using the MSD platform in the 346 serum samples from the Lung Team Project 2 (LTP2).
Aims
We will assess the performance of the candidate antibody biomarkers using ELISA and the candidate serum protein markers using the MSD platform in the 346 serum samples from the Lung Team Project 2 (LTP2).
Analytic Method
Analyzed by DMCC
Outcome
We will assess the performance of the candidate antibody biomarkers using ELISA and the candidate serum protein markers using the MSD platform in the 346 serum samples from the Lung Team Project 2 (LTP2).
Publications
- No publications available at this time for this protocol.
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
- Start Date
- Nov 1 2024
- Estimated Finish Date
- May 1 2025
- Protocol ID
- 559
- Protocol Type
- Validation
- Fields of Research
-
- Genomics
- Proteomics
- Collaborative Group
- Lung and Upper Aerodigestive Cancers Research Group
- Cancer Types
-
- Malignant neoplasm of bronchus and lung
- Phased Status
- 2